ZA200704775B - Compositions for treatment of ear infections - Google Patents

Compositions for treatment of ear infections

Info

Publication number
ZA200704775B
ZA200704775B ZA200704775A ZA200704775A ZA200704775B ZA 200704775 B ZA200704775 B ZA 200704775B ZA 200704775 A ZA200704775 A ZA 200704775A ZA 200704775 A ZA200704775 A ZA 200704775A ZA 200704775 B ZA200704775 B ZA 200704775B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
ear infections
infections
ear
Prior art date
Application number
ZA200704775A
Other languages
English (en)
Inventor
Geoffrey R Owen
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of ZA200704775B publication Critical patent/ZA200704775B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/488—Aspartic endopeptidases (3.4.23), e.g. pepsin, chymosin, renin, cathepsin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4826—Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200704775A 2004-12-10 2005-09-14 Compositions for treatment of ear infections ZA200704775B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63521804P 2004-12-10 2004-12-10

Publications (1)

Publication Number Publication Date
ZA200704775B true ZA200704775B (en) 2008-08-27

Family

ID=36588301

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200704775A ZA200704775B (en) 2004-12-10 2005-09-14 Compositions for treatment of ear infections

Country Status (11)

Country Link
US (1) US20070212343A1 (fr)
EP (1) EP1824499A2 (fr)
JP (1) JP2008523060A (fr)
KR (1) KR20070089222A (fr)
CN (1) CN101072571A (fr)
AU (1) AU2005317228A1 (fr)
BR (1) BRPI0518891A2 (fr)
CA (1) CA2587081A1 (fr)
MX (1) MX2007005980A (fr)
WO (1) WO2006065301A2 (fr)
ZA (1) ZA200704775B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220431B2 (en) 2002-11-27 2007-05-22 Regents Of The University Of Minnesota Methods and compositions for applying pharmacologic agents to the ear
US20120253267A1 (en) * 2004-05-24 2012-10-04 Reed Don C Combined otic and medication dispenser and method for treating otic infections
WO2008085913A1 (fr) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Procédés pour traiter, prévenir, ou réduire le risque d'infections ophtalmiques, otiques, et nasales
TW201010727A (en) * 2008-09-03 2010-03-16 Alcon Res Ltd Pharmaceutical composition having relatively low ionic strength
DK2521547T3 (da) * 2010-01-07 2017-11-20 Novartis Ag Fremgangsmåder og sammensætninger til påføring af moxifloxacin til ørene
US20170071979A1 (en) * 2011-05-11 2017-03-16 Veloce Biopharma, Llc Composition and method for treating otitis
CN114901291A (zh) 2019-10-18 2022-08-12 托皮科斯药品公司 抗菌有机硅烷

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61282313A (ja) * 1985-06-06 1986-12-12 Nitto Electric Ind Co Ltd 酵素含有貼付剤
US5061729A (en) * 1988-06-08 1991-10-29 Biogal Gyogyszergyar Pharmaceutical composition and process for preparing the same
EP0577200B1 (fr) * 1992-07-02 1996-07-03 Laboratorios Cusi, S.A. Récipient pour produits pharmaceutiques à deux composants séparés, comprenant un dispositif de mélange, et de distribution dosée
DE59409595D1 (de) * 1993-12-21 2000-12-28 Boehringer Ingelheim Pharma Anellierte dihydropyridine und deren verwendung für die herstellung von pharmazeutischen zubereitungen
US5397578A (en) * 1994-03-29 1995-03-14 Tovarischestvo S Ogranichennoi Otvetstvennostiju "Taurus" Method of treatment of chronic purulent inflammations of ear in children
ES2128220B1 (es) * 1995-12-04 1999-12-16 Cusi Lab Envase farmaceutico de dos sustancias separadas, con dispositivo de mezcla, aplicacion dosificada y su proceso de montaje.
US20040126515A1 (en) * 1995-12-27 2004-07-01 Yarmoska Bruce S. Wood-plastic composite having improved strength
US5954682A (en) * 1996-09-25 1999-09-21 Advanced Medical Instruments Therapeutic applicator apparatus and method
IT1284973B1 (it) * 1996-10-11 1998-05-28 A R D O Associazione Ricerca E Uso del sodio 2-mercaptoetansolfonato (mesna) in chirurgia
US20020136712A1 (en) * 1997-10-31 2002-09-26 Fischetti Vincent Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US6716830B2 (en) * 1998-09-30 2004-04-06 Alcon, Inc. Ophthalmic antibiotic compositions containing moxifloxacin
US6093417A (en) * 1999-01-11 2000-07-25 Advanced Medical Instruments Composition to treat ear disorders
US6214339B1 (en) * 2000-01-12 2001-04-10 Michael A. Pellico Di-enzymatic treatment of outer ear infection in dogs and cats
KR100338327B1 (ko) * 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
WO2004054513A2 (fr) * 2002-12-12 2004-07-01 Activbiotics, Inc. Methodes et compositions de traitement et de prevention d'infections auriculaires

Also Published As

Publication number Publication date
US20070212343A1 (en) 2007-09-13
WO2006065301A3 (fr) 2006-09-08
MX2007005980A (es) 2007-07-10
CN101072571A (zh) 2007-11-14
BRPI0518891A2 (pt) 2008-12-16
CA2587081A1 (fr) 2006-06-22
AU2005317228A1 (en) 2006-06-22
WO2006065301A2 (fr) 2006-06-22
EP1824499A2 (fr) 2007-08-29
KR20070089222A (ko) 2007-08-30
JP2008523060A (ja) 2008-07-03

Similar Documents

Publication Publication Date Title
IL257622B (en) Methods and preparations for the treatment of persistent infections
HK1134679A1 (zh) 用於治療感染的組合物和方法
IL179873A0 (en) Methods of treatment of endobronchial infections
IL186578A0 (en) Compositions for treatment of neovascularization diseases
IL178207A0 (en) Dalbavancin compositions for treatment of bacterial infections
EP1871331A4 (fr) Composition pour le traitement de la menopause
IL189622A0 (en) Pharmaceutical compositions for the treatment of inner ear disorders
PL1765391T3 (pl) Kompozycje bakteryjne do leczenia nowotworów
IL190779A0 (en) Compositions for treatment of eye diseases
IL195272A0 (en) Methods and compositions for the treatment of viral infections
GB0513096D0 (en) Treatment of microbial infections
IL182993A0 (en) Treatment of mastitis
ZA200704775B (en) Compositions for treatment of ear infections
GB0605715D0 (en) Treatment of laminitis
GB0422439D0 (en) Inhibitors of infection
IL180459A0 (en) Treatment of bacterial infections
GB0504333D0 (en) Treatment of cytokine dysregulation
PL3184150T3 (pl) Leczenie zakażeń kieszonki poddziąsłowej
MY144154A (en) Method of combating infection
HUP0500947A2 (en) Composition for treatment of paradontosis
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
HU0400952D0 (en) Treatment of anus-cancer
GB0518003D0 (en) Treatment of hepatatis c
AU2005903359A0 (en) Treatment of sheep to reduce flystrike